Oncology infusion centers run on short windows of attention. A nurse hangs the drug, checks the line, confirms vitals, watches for early signs of distress, and moves to the next chair. Most of the time that workflow works. The problem is what happens between spot checks. Infusion-related reactions can escalate quickly, and chemotherapy patients often arrive with cardiopulmonary risk, fatigue, dehydration, or treatment-related instability already in the background.
Camera-based vital sign monitoring is starting to matter in that gap. The technology is still early for oncology-specific deployment, but the direction is clear: infusion suites want better surveillance without adding more cuffs, cables, clips, and patient friction.
"Infusion-related reactions in cancer therapy require careful monitoring, prompt recognition, and appropriate management to ensure patient safety." — Antonio Araújo and colleagues, ESMO Open (2024)
Why oncology infusion centers are a strong fit for camera-based vital signs
The workflow in an infusion center is different from a ward or ICU. Patients are seated for long periods, usually facing forward, often under stable lighting, and they move less than patients walking through an emergency department. From a sensing perspective, that is a useful environment for remote photoplethysmography, or rPPG, which estimates physiologic signals from subtle skin-color changes captured by a standard camera.
Linas Saikevičius, Vidas Raudonis, Gintaras Dervinis, and Virginijus Baranauskas wrote in their 2024 Sensors review that non-contact vision-based monitoring can support heart rate, respiratory rate, oxygen saturation, and blood pressure estimation, though performance still depends on lighting, skin tone, motion, and camera angle. That caveat matters. Infusion centers are one of the few ambulatory environments where some of those variables can actually be managed.
The clinical need is not abstract. Antonio Araújo and co-authors noted in ESMO Open that severe infusion-related reactions can range from under 1% to roughly 30% depending on the therapy. Most chairs stay uneventful. A small subset does not. That is exactly the kind of environment where continuous trend awareness can be more valuable than occasional manual confirmation.
| Monitoring approach | What it captures well | Friction for oncology patients | Fit for infusion chairs | Main limitation |
|---|---|---|---|---|
| Manual spot checks | Confirmed vital signs at a single moment | Moderate | Standard of care | Misses changes between checks |
| Wearables or wired sensors | Continuous physiologic data | Moderate to high | Useful in selected patients | Adhesion, setup, charging, cables |
| Connected cuff and pulse oximeter | Repeated scheduled measurements | Moderate | Familiar workflow | Still intermittent and device-dependent |
| Camera-based vital signs | Passive trend monitoring from a chairside view | Low | Strong if environment is controlled | Sensitive to lighting, motion, and workflow design |
A camera system will not diagnose the cause of a reaction. It will not tell staff whether a patient is developing hypersensitivity, vasovagal symptoms, anxiety, or disease-related deterioration. What it can do is flag that the patient in chair 7 no longer looks physiologically stable compared with five minutes ago.
A few practical advantages stand out:
- Patients in chemotherapy suites already carry enough equipment and discomfort.
- Staff need visibility across many chairs at once, not just bedside data for one patient.
- Trend monitoring matters most during drug initiation, rate changes, and the first minutes after symptoms appear.
- Contactless systems can potentially observe patients who dislike repeated cuff inflation or finger probes.
Clinical applications in oncology infusion monitoring
Watching for infusion-related reactions between manual checks
This is the most obvious use case. Araújo and colleagues argued that the safety gap in cancer therapy is not just treatment toxicity. It is also inconsistency in how institutions prevent, recognize, and report infusion reactions. A contactless monitoring layer does not solve that variation, but it could make physiologic change more visible during the period when staff are multitasking across a full room.
Heart-rate acceleration, respiratory-rate change, visible distress, pallor shifts, or a falling oxygen trend would not be diagnostic on their own. Still, they can help a nurse decide to reassess sooner rather than later.
Supporting higher-volume ambulatory oncology operations
Most infusion centers are labor constrained. The issue is rarely whether nurses know what to look for. The issue is whether they can see everything quickly enough while managing medications, pumps, documentation, and patient communication.
That is why oncology remote monitoring research matters here even when it does not focus on cameras specifically. Reema Moussa and colleagues reported in their 2025 ASCO Quality Care Symposium systematic review that 38 randomized oncology RPM trials covered 13,627 patients, with most studies published from 2020 to 2024. The field is moving toward more structured monitoring outside and between clinic encounters because cancer care keeps generating more data than staff can manually track.
Creating a softer patient experience during long visits
Cancer patients often spend hours in the chair. Some are frail, nauseated, dyspneic, or exhausted before treatment even begins. Contactless monitoring is not just an efficiency argument. In the right workflow, it can reduce how often staff need to interrupt rest for routine observation, especially when the goal is trend awareness rather than another full set of manual vitals.
That does not mean eliminating standard checks. It means reserving active measurement for the moments when it actually changes care.
Current research and evidence
The oncology-specific evidence base for contactless vital signs is still thin, which is worth saying plainly. The best current argument for camera-based monitoring in infusion suites comes from combining three evidence streams rather than pretending one definitive oncology camera trial already exists.
The first stream is general non-contact vital sign research. Saikevičius and colleagues reviewed the modern vision-based literature in 2024 and concluded that rPPG has become a credible platform for multi-parameter monitoring, especially when paired with better preprocessing and machine-learning pipelines. Their review also makes the limits clear: skin tone effects, ambient light, gaze direction, and motion still shape performance.
The second stream is cancer remote monitoring research. Moussa and colleagues' 2025 systematic review shows that oncology programs are already investing in remote surveillance for symptoms, health status, and biometric signals. Not every study used cameras. Many relied on web tools, apps, phone follow-up, or wearables. But the operational need is the same: oncology teams want earlier visibility into physiologic and symptom change without increasing patient burden.
The third stream is infusion-safety literature. Araújo and colleagues wrote in 2024 that infusion-related reactions remain difficult partly because prevention and response are not standardized across institutions. That makes structured observation more important, not less. If a center wants to catch deterioration earlier, it needs more continuous awareness than the classic pattern of spot checks can provide.
The future of camera-based monitoring in cancer care
The near-term future is probably not a fully autonomous infusion chair. It is a hybrid model.
Manual vitals will stay. Nurse assessment will stay. Emergency protocols will stay. What changes is the amount of passive observation happening between those moments.
If camera-based vital signs mature in oncology, expect deployment to start in narrow, operationally clear cases:
- high-volume infusion suites with repeated monitoring burden
- first-dose or high-risk infusion workflows
- chairside escalation dashboards for nursing teams
- post-infusion observation bays where staff cover many patients at once
Circadify has developed camera-based vital sign estimation capabilities for settings that need lower-friction physiologic observation. Oncology infusion is one of those settings where the technology makes intuitive workflow sense, even if the evidence base is still early and the implementation details will decide whether it succeeds.
The real question is not whether infusion centers need more data. They already have plenty. The question is whether they can get earlier, lower-friction signals that fit the way oncology care is actually delivered. That is where camera-based vital signs may earn a place.
Frequently asked questions
Can camera-based vital signs replace nurse observation in an infusion center?
No. In oncology infusion settings, camera-based vital signs are better understood as an additional layer of observation rather than a replacement for nursing judgment, bedside assessment, or emergency response protocols.
Which vital signs are most relevant for chemotherapy chairside monitoring?
Heart rate, respiratory rate, oxygen saturation trends, and blood pressure context are the most relevant parameters for detecting discomfort, physiologic deterioration, or infusion-related reactions during treatment sessions.
Why are infusion centers interested in contactless monitoring?
Infusion centers manage high patient volume, repeated spot checks, and time-sensitive reactions. Contactless systems may help staff watch trend changes between manual observations without adding more wearables or cables to already complex workflows.
Is contactless monitoring already common in oncology?
Not yet. The published literature suggests oncology remote monitoring is growing, but cancer-specific contactless vital sign monitoring remains early. Most current evidence comes from broader remote monitoring programs, wearables, and general non-contact vital sign research.
Related Articles
- Camera-Based Vital Signs in Clinical Trials: How rPPG Is Changing Drug Development — Why sponsors want lower-friction vital sign capture outside traditional sites.
- Remote Patient Monitoring Reduces Readmissions — The broader care-delivery case for closer monitoring beyond episodic visits.
- Privacy and Data Security in Camera-Based Health Monitoring — The governance questions that matter any time video-based monitoring enters patient care.